Theralase Technologies has two divisions. The Therapeutic Laser Technology division designs, develops, manufactures and distributes the TLC-2000 Theralase superpulsed laser technologies intended to provide healthcare practitioners technology for the elimination of pain, reduction in inflammation and acceleration of tissue healing for chronic knee pain. The Photo Dynamic Therapy division focuses on research, development and commercialization of TLC-3000 PDC anti-cancer technology through preclinical scientific research, clinical trials and technology development intended to treat patients inflicted with various cancers and to destroy bacteria for human, animal and sterilization applications.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.